NasdaqGM - Delayed Quote USD

Quantum-Si incorporated (QSI)

1.6500 +0.0400 (+2.48%)
At close: April 26 at 4:00 PM EDT
1.6500 0.00 (0.00%)
After hours: April 26 at 4:43 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,082.0000
1,082.0000
--
--
--
Cost of Revenue
594.0000
594.0000
--
--
--
Gross Profit
488.0000
488.0000
--
--
--
Operating Expense
111,659.0000
111,659.0000
114,358.0000
96,908.0000
36,691.0000
Operating Income
-111,171.0000
-111,171.0000
-114,358.0000
-96,908.0000
-36,691.0000
Net Non Operating Interest Income Expense
--
--
--
-5.0000
-9.0000
Other Income Expense
15,211.0000
15,211.0000
-18,084.0000
1,924.0000
87.0000
Pretax Income
-95,960.0000
-95,960.0000
-132,442.0000
-94,989.0000
-36,613.0000
Net Income Common Stockholders
-95,960.0000
-95,960.0000
-132,442.0000
-94,989.0000
-36,613.0000
Diluted NI Available to Com Stockholders
-95,960.0000
-95,960.0000
-132,442.0000
-94,989.0000
-36,613.0000
Basic EPS
-0.68
--
-0.95
-1.19
-0.27
Diluted EPS
-0.68
--
-0.95
-1.19
-0.27
Basic Average Shares
141,300.0000
--
139,255.0000
79,579.0000
136,400.6600
Diluted Average Shares
141,300.0000
--
139,255.0000
79,579.0000
136,400.6600
Total Operating Income as Reported
-111,171.0000
-111,171.0000
-123,841.0000
-96,908.0000
-36,691.0000
Total Expenses
112,253.0000
112,253.0000
114,358.0000
96,908.0000
36,691.0000
Net Income from Continuing & Discontinued Operation
-95,960.0000
-95,960.0000
-132,442.0000
-94,989.0000
-36,613.0000
Normalized Income
-110,805.0000
-110,805.0000
-113,900.0000
-96,894.0000
-36,710.0000
Interest Expense
--
--
--
5.0000
9.0000
Net Interest Income
--
--
--
-5.0000
-9.0000
EBIT
-95,960.0000
-95,960.0000
-132,442.0000
-94,984.0000
-36,604.0000
EBITDA
-91,804.0000
-91,804.0000
-129,858.0000
-93,943.0000
-35,710.0000
Reconciled Cost of Revenue
594.0000
594.0000
--
--
--
Reconciled Depreciation
4,156.0000
4,156.0000
2,584.0000
1,041.0000
894.0000
Net Income from Continuing Operation Net Minority Interest
-95,960.0000
-95,960.0000
-132,442.0000
-94,989.0000
-36,613.0000
Total Unusual Items Excluding Goodwill
14,845.0000
14,845.0000
-18,542.0000
1,905.0000
97.0000
Total Unusual Items
14,845.0000
14,845.0000
-18,542.0000
1,905.0000
97.0000
Normalized EBITDA
-106,649.0000
-106,649.0000
-111,316.0000
-95,848.0000
-35,807.0000
12/31/2020 - 11/13/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NAUT Nautilus Biotechnology, Inc.
2.4900
+5.51%
 
CRBU Caribou Biosciences, Inc.
3.7100
-1.33%
 
DNA Ginkgo Bioworks Holdings, Inc.
0.8601
+10.60%
 
BEAM Beam Therapeutics Inc.
21.38
-1.02%
 
RNA Avidity Biosciences, Inc.
24.36
+2.22%
 
VERV Verve Therapeutics, Inc.
6.16
-0.96%
 
EDIT Editas Medicine, Inc.
5.32
+1.92%
 
SANA Sana Biotechnology, Inc.
8.72
+2.59%
 
SEER Seer, Inc.
1.9100
+9.14%
 
ERAS Erasca, Inc.
1.8900
+0.53%